Closing The Books On GDUFA II: How Generics Fared At US FDA Over The Last Five Years

Sponsors sent nearly 4,500 ANDAs and the US Food and Drug Administration approved nearly 3,900 throughout the last five-year generic drug user fee cycle.

Agency data suggests a mostly steady volume of ANDA approvals and submissions during the program cycle, save for fiscal year...